Feature | Dave Fornell

Endovascular repair for aortic aneurysms has gained popularity in the past five to six years as physicians has learned how to use and became more comfortable with the new generations of stent graft technology.

Home March 19, 2009
Home
News

March 19, 2009 - Sorin Group and Orange Business Services today entered into an agreement to develop and service a remote monitoring solution for patients implanted with cardiac rhythm management (CRM) devices.

Home March 19, 2009
Home
News

March 19, 2009 – The 18th annual Interventional Cardiology Symposium will take place June 18-20 in Montreal, Canada.

Home March 19, 2009
Home
News

March 19, 2009 - The Drug Information Association (DIA), in cooperation with the Heart Rhythm Society (HRS) and the FDA, will host Cardiovascular Safety and QT/Arrhythmia Assessment in Drug Development: Optimizing Drug Development Wednesday, April 29 – Friday, May 1 in Bethesda, MD.

Home March 19, 2009
Home
News

March 19, 2009 – The Society of Nuclear Medicine (SNM) will host a two-day symposium Thursday, April 30–Friday, May 1 focused on advances in stem cell therapy, leading-edge research in imaging technology and targeted imaging of the cardiovascular system, including imaging of cardiovascular receptors, vascular biology, myocardial metabolism and myocardial repair.

Home March 19, 2009
Home
News

March 19, 2009 - Sanofi-aventis said yesterday the FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-3 in favor of the approval of Multaq (dronedarone) to treat patients with non-permanent atrial fibrillation (AF).

Home March 19, 2009
Home
News

March 19, 2009 – Led by Senator Richard Durbin (D-IL) and Congressman Zack Space (D-OH), the federal government yesterday introduced new legislation that will address the needs of those affected by congenital heart defects (CHDs).

Home March 19, 2009
Home
News

March 19, 2009 - The LUMEN 2009: The Symposium on Optimal Treatments for Acute MI recently hosted hundreds of paramedics, emergency department staff, nurses, internists, hospitalists, interventional cardiologists, cardiac and vascular surgeons, and hospital administrators, to discuss the state of America’s healthcare system and the fight to save vulnerable heart attack patients.

Home March 19, 2009
Home
News

March 19, 2009 - The FDA has approved an investigational device exemption (IDE) for a multicenter clinical trial of IDEV Technologies Inc.’s SUPERA stent, a novel stent platform designed for the treatment of peripheral artery disease (PAD) in the superficial femoral artery (SFA).

Home March 19, 2009
Home
Technology

March 19, 2009 - Digisonics will showcase their new DigiView Cath package with its imaging and reporting capabilites for the first time at the ACC 2009 meeting in Orlando, FL at booth #1773.

Home March 19, 2009
Home
News

March 18, 2009 - Flexible Stenting Solutions Inc. (FSS) this week submitted an investigational device exemption (IDE) application to the FDA for its FlexStent Femoropopliteal SE Stent System for the treatment of peripheral artery disease in the superficial femoral and popliteal arteries.

Home March 18, 2009
Home
News

March 18, 2009 - Cardiologists Edward Tadajweski, M.D., and Jeffrey L. Williams, M.D., MS, FACC, are the first in the U.S. to perform 3D imaging of complex cardiac anatomy using GE's Innova 3D imaging system.

Home March 18, 2009
Home
News

March 18, 2009 - The U.S. Preventive Services Task Force (USPSTF) found that regular aspirin use reduces first heart attacks in men and first strokes in women and recommends daily aspirin use for certain patient populations.

Home March 18, 2009
Home
News

March 18, 2009 - The success of Massachusetts hospitals and physicians to incorporate information technology (IT) into healthcare demonstrates the importance of incentives, according to two studies conducted by CSC and sponsored by Blue Cross Blue Shield of Massachusetts.

Home March 18, 2009
Home
News

March 18, 2009 - GE said yesterday it was awarded two 10-year contracts by the Defense Supply Center Philadelphia (DSCP) to provide products for comprehensive patient monitoring solutions, including acute patient monitoring, networking, telemetry systems, vital signs monitoring. Combined, these two contracts are valued at a maximum of $63 million annually.

Home March 18, 2009
Home
Subscribe Now